{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:34:00Z","timestamp":1768347240191,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.pcad.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T19:57:08Z","timestamp":1564689428000},"page":"358-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The role of coronary artery bypass surgery versus percutaneous intervention in patients with diabetes and coronary artery disease"],"prefix":"10.1016","volume":"62","author":[{"given":"Lucas C.","family":"Godoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis T.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2019.07.004_bb0005","series-title":"IDF Diabetes Atlas","article-title":"International diabetes federation","year":"2017"},{"key":"10.1016\/j.pcad.2019.07.004_bb0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijcard.2016.04.182","article-title":"A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction","volume":"217","author":"Bauters","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0015","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2006.11.048","article-title":"The final 10-year follow-up results from the BARI randomized trial","volume":"49","author":"The BARI Investigators","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.298.7.765","article-title":"Diabetes and mortality following acute coronary syndromes","volume":"298","author":"Donahoe","year":"2007","journal-title":"Jama"},{"key":"10.1016\/j.pcad.2019.07.004_bb0025","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/01.CIR.96.6.1761","article-title":"Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization investigation (BARI)","volume":"96","author":"The BARI Investigators","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2019.07.004_bb0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199607253350401","article-title":"Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease","volume":"335","author":"The BARI Investigators","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.07.004_bb0035","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.07.004_bb0040","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.07.004_bb0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jacc.2009.09.057","article-title":"Diabetic and nondiabetic patients with left main and\/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents","volume":"55","author":"Banning","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0050","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ejcts\/ezt017","article-title":"Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial","volume":"43","author":"Kappetein","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pcad.2019.07.004_bb0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2009.10.014","article-title":"Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial","volume":"55","author":"Kapur","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0060","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jacc.2012.11.044","article-title":"Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes","volume":"61","author":"Kamalesh","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0065","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.07.004_bb0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2018.11.001","article-title":"Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM follow-on study","volume":"73","author":"Farkouh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0075","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.jacc.2018.09.046","article-title":"SYNTAX score in patients with diabetes undergoing coronary revascularization in the FREEDOM trial","volume":"72","author":"Esper","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"40","key":"10.1016\/j.pcad.2019.07.004_bb0080","first-page":"87","article-title":"ESC\/EACTS guidelines on myocardial revascularization","volume":"2019","author":"Neumann","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2019.07.004_bb0085","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2017.02.001","article-title":"Appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease","volume":"69","author":"Patel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0090","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/eurheartj\/ehx138","article-title":"Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials","volume":"38","author":"Cavalcante","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2019.07.004_bb0095","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jacc.2018.11.053","article-title":"PCI and CABG for treating stable coronary artery disease: JACC review topic of the week","volume":"73","author":"Doenst","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","article-title":"Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data","volume":"391","author":"Head","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2019.07.004_bb0105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacc.2018.04.071","article-title":"Stroke rates following surgical versus percutaneous coronary revascularization","volume":"72","author":"Head","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0110","first-page":"2059","article-title":"Lifestyle interventions in diabetes and coronary disease","volume":"73","author":"Farkouh","year":"2019","journal-title":"A Timely Reminder"},{"key":"10.1016\/j.pcad.2019.07.004_bb0115","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacc.2015.06.019","article-title":"Comprehensive cardiovascular risk factor control improves survival: the BARI 2D trial","volume":"66","author":"Bittner","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0120","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2018.11.067","article-title":"Lifestyle, glycosylated hemoglobin A1c, and survival among patients with stable ischemic heart disease and diabetes","volume":"73","author":"Mancini","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0125","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.2337\/dc19-S010","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcad.2019.07.004_bb0130","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jacc.2013.01.044","article-title":"Risk factor control for coronary artery disease secondary prevention in large randomized trials","volume":"61","author":"Farkouh","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jacc.2017.11.068","article-title":"Compliance with guideline-directed medical therapy in contemporary coronary revascularization trials","volume":"71","author":"Pinho-Gomes","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0140","first-page":"653","article-title":"The potential effects of new stent platforms for coronary revascularization in patients with diabetes","volume":"34","author":"Guandalini","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0145","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jacc.2017.07.781","article-title":"Type 1 diabetes, coronary disease complexity, and optimal revascularization strategy","volume":"70","author":"Domanski","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0150","doi-asserted-by":"crossref","first-page":"e5170","DOI":"10.1136\/bmj.e5170","article-title":"Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials","volume":"345","author":"Bangalore","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2019.07.004_bb0155","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMoa1510188","article-title":"Paclitaxel-eluting versus everolimus-eluting coronary stents in diabetes","volume":"373","author":"Kaul","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.07.004_bb0160","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCINTERVENTIONS.114.001346","article-title":"Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?","volume":"7","author":"Bangalore","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2019.07.004_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002626","article-title":"Everolimus eluting stents versus coronary artery bypass graft surgery for patients with diabetes mellitus and multivessel disease","volume":"8","author":"Bangalore","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2019.07.004_bb0170","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa1415447","article-title":"Trial of everolimus-eluting stents or bypass surgery for coronary disease","volume":"372","author":"Park","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.07.004_bb0175","doi-asserted-by":"crossref","first-page":"E1641","DOI":"10.21037\/jtd.2016.12.34","article-title":"Coronary surgery in elderly: it is never too late","author":"Chivasso","year":"2016","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.pcad.2019.07.004_bb0180","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1093\/eurheartj\/ehw378","article-title":"Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease","volume":"37","author":"Baber","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2019.07.004_bb0185","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jacc.2018.11.044","article-title":"Impact of chronic kidney disease on outcomes of myocardial revascularization in patients with diabetes","volume":"73","author":"Farkouh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0190","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jacc.2017.12.024","article-title":"Coronary artery bypass surgery improves outcomes in patients with diabetes and left ventricular dysfunction","volume":"71","author":"Nagendran","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0195","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.amjcard.2017.04.038","article-title":"Comparison of outcome of coronary artery bypass grafting versus drug-eluting stent implantation for non-ST-elevation acute coronary syndrome","volume":"120","author":"Chang","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/CIRCOUTCOMES.115.002084","volume":"9","author":"Pandey","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.pcad.2019.07.004_bb0205","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002032","article-title":"Surgical versus percutaneous coronary revascularization for multivessel disease in diabetic patients with non-ST-segment-elevation acute coronary syndrome: analysis from the Acute Catheterization and Early Intervention Triage Strategy trial","volume":"8","author":"Ben-Gal","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2019.07.004_bb0210","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.jacc.2017.10.029","article-title":"Surgical versus percutaneous coronary revascularization in patients with diabetes and acute coronary syndromes","volume":"70","author":"Ramanathan","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0215","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.jacc.2017.10.070","article-title":"Do we need a trial of DES versus CABG surgery in diabetic patients with ACS?","volume":"70","author":"Bangalore","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0220","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2016.06.024","article-title":"Outcomes after percutaneous coronary intervention or bypass surgery in patients with unprotected left main disease","volume":"68","author":"Cavalcante","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0225","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/S0140-6736(16)32052-9","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial","volume":"388","author":"M\u00e4kikallio","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2019.07.004_bb0230","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","article-title":"Everolimus-eluting stents or bypass surgery for left main coronary artery disease","volume":"375","author":"Stone","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.07.004_bb0235","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jacc.2019.01.037","article-title":"Bypass surgery or stenting for left main coronary artery disease in patients with diabetes","volume":"73","author":"Milojevic","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.07.004_bb0240","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1161\/CIRCULATIONAHA.118.035970","article-title":"Myocardial revascularization trials","volume":"138","author":"Ruel","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2019.07.004_bb0245","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacc.2019.02.005","article-title":"Diabetes in myocardial revascularization for left main coronary artery disease: predictor or decision maker?","volume":"73","author":"Park","year":"2019","journal-title":"J Am Coll Cardiol"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003306201930101X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003306201930101X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:16:22Z","timestamp":1758500182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003306201930101X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S003306201930101X"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2019.07.004","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of coronary artery bypass surgery versus percutaneous intervention in patients with diabetes and coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}